World's Best Scientists 2026 revealed!
Dimitri Lavillette

Dimitri Lavillette

D-Index & Metrics

Biology and Biochemistry

D-Index
47
Citations
9702
World Ranking
18637
National Ranking
492

Dimitri Lavillette publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Dimitri Lavillette sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 116 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Dimitri Lavillette D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Dimitri Lavillette sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 47 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Dimitri Lavillette is affiliated with the Chinese Academy of Sciences in China. Their primary research focus lies within the field of Medicine, with a specialization in Infectious Diseases. Additional areas of study include Molecular Biology, Radiology, Nuclear Medicine and Imaging, Animal Science and Zoology, and Ecology.

The scientist's research topics cover various aspects of viral infections and immunology, particularly centered on coronaviruses and COVID-19. Key themes in their work include:

  • SARS-CoV-2 and COVID-19 Research
  • Monoclonal and Polyclonal Antibodies Research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Bacteriophages and Microbial Interactions
  • Viral Gastroenteritis Research and Epidemiology
  • Mosquito-Borne Diseases and Control

Dimitri Lavillette has published extensively in several scientific journals. Frequent publication venues are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS Pathogens
  • Nature Communications
  • Cell Discovery
  • Journal of Biological Chemistry

Representative recent papers include:

  • "The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles" (2020, Journal of Biological Chemistry)
  • "SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation" (2021, Proceedings of the National Academy of Sciences)
  • "Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections" (2021, Nature Communications)
  • "A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection" (2021, Nature Communications)
  • "Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement" (2020, Cell Discovery)

The scientist has collaborated regularly with several co-authors including Bingjie Zhou, Dianfan Li, Zhong Huang, Chao Zhang, and Shiqi Xu. Their partnerships reflect focused research efforts in the investigation of viral mechanisms and antibody responses.

Best Publications

  • EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

    Joachim Lupberger;Mirjam B Zeisel;Mirjam B Zeisel;Fei Xiao;Fei Xiao;Christine Thumann;Christine Thumann

  • An Envelope Glycoprotein of the Human Endogenous Retrovirus HERV-W Is Expressed in the Human Placenta and Fuses Cells Expressing the Type D Mammalian Retrovirus Receptor

    Jean-Luc Blond;Dimitri Lavillette;Valérie Cheynet;Olivier Bouton

  • An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

    Birke Bartosch;Géraldine Verney;Marlène Dreux;Peggy Donot

  • Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.

    Dimitri Lavillette;Yoann Morice;Georgios Germanidis;Peggy Donot

  • Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.

    Dimitri Lavillette;Alexander W. Tarr;Cécile Voisset;Peggy Donot

  • Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

    Ania Owsianka;Alexander W. Tarr;Vicky S. Juttla;Dimitri Lavillette

  • The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles.

    Bertrand Boson;Vincent Legros;Bingjie Zhou;Eglantine Siret

  • The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus

    Laurent Meertens;Claire Bertaux;Lisa Cukierman;Emmanuel Cormier

  • High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.

    Marlène Dreux;Marlène Dreux;Thomas Pietschmann;Christelle Granier;Christelle Granier;Cécile Voisset

  • Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus

    Dimitri Lavillette;Eve-Isabelle Pécheur;Peggy Donot;Judith Fresquet

  • The Envelope Glycoprotein of Human Endogenous Retrovirus Type W Uses a Divergent Family of Amino Acid Transporters/Cell Surface Receptors

    Dimitri Lavillette;Mariana Marin;Alessia Ruggieri;François Mallet

  • Fusogenic Membrane Glycoproteins As a Novel Class of Genes for the Local and Immune-mediated Control of Tumor Growth

    Andrew Bateman;Francis Bullough;Stephen Murphy;Lisa Emiliusen

  • The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection

    Ignacio Benedicto;Francisca Molina-Jiménez;Birke Bartosch;François-Loïc Cosset;François-Loïc Cosset;François-Loïc Cosset

  • Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening

    Maud Trotard;Maud Trotard;Charlotte Lepère-Douard;Charlotte Lepère-Douard;Morgane Régeard;Morgane Régeard;Claire Piquet-Pellorce

  • Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes *

    Dimitri Lavillette;Birke Bartosch;Delphine Nourrisson;Gérelidine Verney

  • Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.

    Marlène Dreux;Viet Loan Dao Thi;Judith Fresquet;Maryse Guérin

  • A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques

    Pierre Garrone;Anne-Catherine Fluckiger;Philippe E. Mangeot;Emmanuel Gauthier

  • Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.

    Viet Loan Dao Thi;Christelle Granier;Mirjam B. Zeisel;Mirjam B. Zeisel;Maryse Guérin

  • N-Linked Glycosylation and Sequence Changes in a Critical Negative Control Region of the ASCT1 and ASCT2 Neutral Amino Acid Transporters Determine Their Retroviral Receptor Functions

    Mariana Marin;Dimitri Lavillette;Sean M. Kelly;David Kabat

  • A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes

    Dimitri Lavillette;Marielle Maurice;Catherine Roche;Stephen J. Russell

Frequent Co-Authors

François-Loïc Cosset
François-Loïc Cosset Claude Bernard University Lyon 1
Mirjam B. Zeisel
Mirjam B. Zeisel University of Strasbourg
Thomas F. Baumert
Thomas F. Baumert University of Strasbourg
Els Verhoeyen
Els Verhoeyen Inserm : Institut national de la santé et de la recherche médicale
Jean Dubuisson
Jean Dubuisson Institut Pasteur
Arvind H. Patel
Arvind H. Patel University of Glasgow
David Kabat
David Kabat Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to a variety of career pathways, especially in healthcare and allied health fields. Many students consider advancing with online degrees in related areas, such as an MBA in healthcare management. When exploring these options, it’s important to consider the healthcare mba cost and weigh it against the long-term career benefits.

For those interested in data and administration, medical coding and billing is a growing field offering flexibility and stable job prospects. One common question is, how long does it take to become a medical coder? Typically, you can earn a certification in as little as 9-12 months.

Choosing between different certifications is also crucial. The ccs vs cpc salary comparison provides valuable insights on income potential and job roles for these medical coding credentials.

If you are wondering, is medical coding a good job, it's helpful to review both the advantages and challenges of this in-demand profession before making your decision.

Best Scientists Citing Dimitri Lavillette

Trending Scientists

Recently Published Articles